Clinical Trial

PTSD of Surgeons or Anesthesiologists on Prognosis of Surgical Patients

Completed
View on ClinicalTrials.gov →
Summary
The objective of this prospective cohort study is to explore the association between the development of post-traumatic stress disorder (PTSD) in surgeons and anesthesiologists and postoperative prognosis in surgical patients they care for during the COVID-19 pandemic. There are 2 cohorts included in this study. The first cohort consists of registered surgeons and anesthesiologists in the study center. The development of PTSD will be evaluated with a series of questionnaires and scales. This cohort defines exposure (with PTSD). The second cohort consists of surgical patients managed by the surgeons and anesthesiologists in the first cohort. The postoperative outcome of these patients will be evaluated thus to explore the association between PTSD in physicians and adverse patient outcomes. The second cohort defines the outcomes( response).
Protocol Amendment History 3 changes
critical Trial completed 2026-08-06
notable Enrollment reduced: 10000 -> 356 participants 2026-08-06
notable Primary completion pushed: 2025-11-30 -> 2025-12-31 2026-08-06
Trial Details
NCT Number NCT05732116
Lead Sponsor Xijing Hospital
Collaborators: Ningbo No.2 Hospital
Conditions Post Traumatic Stress Disorder, Postoperative Complications, COVID-19
Enrollment 356 participants
Start Date 2023-02-21
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-05